University of Sydney commits half a billion to upcoming biomedical precinct

The University of Sydney has announced it will invest $478 million in the Sydney Biomedical Accelerator (SBA) biomedical precinct, a partnership between the university, Sydney Local Health District and the NSW Government.

According to a statement made on Monday, the capital investment would be the largest in the university’s history. 

It said the precinct was being benchmarked against world leaders such as the University of Toronto’s MaRS Discovery District and Boston’s MassBio super-cluster, with membership including Harvard, MIT, Brigham and Women’s Hospital, and Boston Children’s Hospital.

The release said the new health, education, and research precinct would cover 36,000 square metres within Sydney’s Tech Central, across Royal Prince Alfred Hospital and the university’s Camperdown campuses. 

“The range of world-class buildings and facilities that will make up the Sydney Biomedical Accelerator will bring together the brightest scientific and clinical minds with entrepreneurs, industry and government,” said University of Sydney Vice Chancellor, Professor Mark Scott.

“It gives our renowned researchers and partners the infrastructure to take a major step forward in the global quest to find solutions to our biggest health challenges.”

The NSW government committed $143.3 million to the project in its June budget. Funding also includes $73 million from philanthropic donations.

Image credit: Denton Corker Marshall

Subscribe to our free @AuManufacturing newsletter here.